Literature DB >> 590917

Failure of exogenous insulin to inhibit insulin secretion in man.

K Shima, S Morishta, N Sawazaki, R Tanaka, S Tarui.   

Abstract

In order to explore whether or not the negative feedback mechanism of insulin per se on insulin secretion exists in man, changes in plasma C-peptide immunoreactivity (CPR), as an index of pancreatic B cells secretory function, were studied in 6 nonobese healthy volunteers in the presence of high circulating levels of exogenous insulin. 10% glucose was infused concurrently so as to maintain blood sugar at the basal level. The insulin-glucose infusion was maintained for 120 minutes, achieving mean plasma levels of 140-180 mu1/ml. After this period, the insulin infusion was continued at the same rate for an additional 10 minutes while the glucose was omitted. Despite the elevated level of circulating insulin, no significant change in plasma CPR concentration was observed so long as the blood sugar was maintained at the basal levels. Following cessation of the glucose infusion, the plasma CPR levels declined with a decrease in blood sugar level. Under the conditions of the present study, no inhibitory effect of exogenous insulin on the secretory function of the B cells was noticed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590917     DOI: 10.1055/s-0028-1093496

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

1.  Identification of functional insulin receptors on membranes from an insulin-producing cell line (RINm5F).

Authors:  H Gazzano; P Halban; M Prentki; R Ballotti; D Brandenburg; M Fehlmann; E Van Obberghen
Journal:  Biochem J       Date:  1985-03-15       Impact factor: 3.857

2.  Attenuation of the pancreatic beta cell response to a meal following hypoglycaemia in man.

Authors:  B M Frier; R J Corrall; J P Ashby; J D Baird
Journal:  Diabetologia       Date:  1980-04       Impact factor: 10.122

3.  The effect of glibenclamide on insulin secretion at normal glucose concentrations.

Authors:  Axel Riefflin; Usha Ayyagari; Susan E Manley; Rury R Holman; Jonathan C Levy
Journal:  Diabetologia       Date:  2014-10-09       Impact factor: 10.122

4.  Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus.

Authors:  Yuichiro Iwamoto; Tomohiko Kimura; Fuminori Tatsumi; Toshitomo Sugisaki; Masato Kubo; Erina Nakao; Kazunori Dan; Ryo Wamata; Hideyuki Iwamoto; Kaio Takahashi; Junpei Sanada; Yoshiro Fushimi; Yukino Katakura; Masashi Shimoda; Shuhei Nakanishi; Tomoatsu Mune; Kohei Kaku; Hideaki Kaneto
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

5.  In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide.

Authors:  E J Verspohl; M Händel; I Hagenloh; H P Ammon
Journal:  Acta Diabetol Lat       Date:  1982 Oct-Dec

6.  Insulin infusion during normoglycemia modulates insulin secretion according to whole-body insulin sensitivity.

Authors:  Christian Anderwald; Andrea Tura; Angela Grassi; Michael Krebs; Julia Szendroedi; Michael Roden; Martin G Bischof; Anton Luger; Giovanni Pacini
Journal:  Diabetes Care       Date:  2011-01-07       Impact factor: 19.112

7.  Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans.

Authors:  Florencia Halperin; Ximena Lopez; Raquel Manning; C Ronald Kahn; Rohit N Kulkarni; Allison B Goldfine
Journal:  Diabetes       Date:  2012-02       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.